BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 15571819)

  • 1. Ubiquitin, proteasome and parkin.
    Tanaka K; Suzuki T; Hattori N; Mizuno Y
    Biochim Biophys Acta; 2004 Nov; 1695(1-3):235-47. PubMed ID: 15571819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impairment of the ubiquitin-proteasome system and neurodegeneration].
    Tanaka K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Apr; 26(2):67-73. PubMed ID: 16722463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkin ubiquitinates and promotes the degradation of RanBP2.
    Um JW; Min DS; Rhim H; Kim J; Paik SR; Chung KC
    J Biol Chem; 2006 Feb; 281(6):3595-603. PubMed ID: 16332688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD).
    Zhou ZD; Sathiyamoorthy S; Angeles DC; Tan EK
    Mol Brain; 2016 Apr; 9():41. PubMed ID: 27090516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease: assays for the ubiquitin ligase activity of neural Parkin.
    Schlossmacher MG; Shimura H
    Methods Mol Biol; 2005; 301():351-69. PubMed ID: 15917645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkin is linked to the ubiquitin pathway.
    Tanaka K; Suzuki T; Chiba T; Shimura H; Hattori N; Mizuno Y
    J Mol Med (Berl); 2001 Sep; 79(9):482-94. PubMed ID: 11692161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.
    Sun F; Kanthasamy A; Anantharam V; Kanthasamy AG
    Pharmacol Ther; 2007 Jun; 114(3):327-44. PubMed ID: 17521740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkin directly modulates 26S proteasome activity.
    Um JW; Im E; Lee HJ; Min B; Yoo L; Yoo J; Lübbert H; Stichel-Gunkel C; Cho HS; Yoon JB; Chung KC
    J Neurosci; 2010 Sep; 30(35):11805-14. PubMed ID: 20810900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin-proteasome system and Parkinson's diseases.
    Betarbet R; Sherer TB; Greenamyre JT
    Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of parkin in Parkinson's disease].
    Miklya I; Göltl P; Hafenscher F; Pencz N
    Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of the parkin gene and protein in understanding Parkinson's disease.
    Fishman PS; Oyler GA
    Curr Neurol Neurosci Rep; 2002 Jul; 2(4):296-302. PubMed ID: 12044248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-protein ligase parkin and its role in the development of Parkinson's disease.
    Buneeva OA; Medvedev AE
    Biochemistry (Mosc); 2006 Aug; 71(8):851-60. PubMed ID: 16978147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of autosomal recessive juvenile Parkinson's disease mutations on the structure and interactions of the parkin ubiquitin-like domain.
    Safadi SS; Barber KR; Shaw GS
    Biochemistry; 2011 Apr; 50(13):2603-10. PubMed ID: 21348451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].
    Corti O; Brice A
    J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity.
    Yao D; Gu Z; Nakamura T; Shi ZQ; Ma Y; Gaston B; Palmer LA; Rockenstein EM; Zhang Z; Masliah E; Uehara T; Lipton SA
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10810-4. PubMed ID: 15252205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkin and the molecular pathways of Parkinson's disease.
    Giasson BI; Lee VM
    Neuron; 2001 Sep; 31(6):885-8. PubMed ID: 11580890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
    Matsuda N; Tanaka K
    J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkin and relatives: the RBR family of ubiquitin ligases.
    Marín I; Lucas JI; Gradilla AC; Ferrús A
    Physiol Genomics; 2004 May; 17(3):253-63. PubMed ID: 15152079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkin and mitochondrial quality control: toward assembling the puzzle.
    Winklhofer KF
    Trends Cell Biol; 2014 Jun; 24(6):332-41. PubMed ID: 24485851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.